Infinity Pharmaceuticals Inc.
INFI
Get informed when a big investor buys or sells
+ FollowMarket Cap$726.09K
Close$
Share Statistics
| Market cap | $726,089.00 |
|---|---|
| Enterprise Value | $-8,110,911.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.48 |
| Beta | 1.38 |
| Outstanding Shares | 89,885,492 |
Return
| Return on Equity | 108.35% |
|---|---|
| Return on Assets | -190.90% |
| Return on Invested Capital | -458.62% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | -3.16 |
| Enterprise Value to EBIT | 0.19 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -1.1 |
| Debt to Equity | -0.24 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Infinity Pharmaceuticals Inc.
CEO: Adelene Perkins